Activated T-lymphocytes (GC Pharma)
- Generic Name
- Activated T-lymphocytes (GC Pharma)
Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea
Not yet recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT06620510
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Phase 3
Recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 408
- Registration Number
- NCT04969731
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01897610
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
🇰🇷Yonsei University Health System, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath